Many cancers have up-regulated epidermal growth factor receptor (EGFr), so we have used antibodies to this receptor (ErbituxTM), and A431 human squamous cell carcinoma cells and tumors which overexpress EGFr. This evidence concerns the gene EGFR and squamous cell carcinoma.